[{"NetIncomeLoss_1_Q2_USD":-67062000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":89744142.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":-11540000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":40141000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":65200000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-14823000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1679338.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-9894000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-6419000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3053000.0,"AssetsCurrent_0_Q2_USD":116908000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-393000.0,"ContractWithCustomerLiability_0_Q2_USD":16667000.0,"DueToRelatedPartiesNoncurrent_0_Q2_USD":253700000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":12547236.0,"DueToRelatedPartiesCurrent_0_Q2_USD":1284000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1388000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3127000.0,"CommonStockSharesIssued_0_Q2_shares":90581003.0,"Assets_0_Q2_USD":135773000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-6419000.0,"ShareBasedCompensation_2_Q2_USD":14736000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10423000.0,"InterestExpenseOther_2_Q2_USD":0.0,"InterestExpenseOther_1_Q2_USD":0.0,"InterestExpenseRelatedParty_2_Q2_USD":4299000.0,"InterestExpenseRelatedParty_1_Q2_USD":2115000.0,"DeferredRevenue_0_Q2_USD":16667000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":89523389.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":31316000.0,"IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1476000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":84707000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":40521000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":15991000.0,"AssetsFairValueDisclosure_0_Q2_USD":69962000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":11081000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":10287000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":6718000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":538000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-134000.0,"NumberOfReportableSegments_2_Q2_segment":1.0,"CommonStockValue_0_Q2_USD":2000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":648000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"IncreaseDecreaseInDueToRelatedPartiesCurrent_2_Q2_USD":1284000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":-0.0054,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.002,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":143578000.0,"RestrictedCash_0_Q2_USD":1987000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":14785000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-109816000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-73481000.0,"OtherAssetsNoncurrent_0_Q2_USD":5634000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":94210000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10127000.0,"Liabilities_0_Q2_USD":335552000.0,"OperatingLeaseLiability_0_Q2_USD":11784000.0,"ProceedsFromRelatedPartyDebt_2_Q2_USD":140000000.0,"MarketableSecuritiesCurrent_0_Q2_USD":17086000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":54144000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-23333000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":4207000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2657000.0,"LeaseCost_2_Q2_USD":1648000.0,"LeaseCost_1_Q2_USD":829000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":18179000.0,"CommonStockSharesOutstanding_0_Q2_shares":90581003.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":28874000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":33333000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":8484057.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-9894000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-6419000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-99384000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-67196000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6924000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-110576000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3028000.0,"LiabilitiesCurrent_0_Q2_USD":66757000.0,"AccountsPayableCurrent_0_Q2_USD":7008000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":96197000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5612000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3578000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2934000.0,"ContractWithCustomerReceivableAfterAllowanceForCreditLoss_0_Q2_USD":0.0,"AdditionalPaidInCapital_0_Q2_USD":702695000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":496078.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingLeasePayments_2_Q2_USD":1463000.0,"OperatingLeasePayments_1_Q2_USD":734000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2808000.0,"NetIncomeLoss_2_Q2_USD":-99922000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-890936000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2409000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4360312.0,"VariableLeaseCost_2_Q2_USD":190000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-8326000.0,"CommonStockSharesAuthorized_0_Q2_shares":564111242.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":33333000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-105518000.0,"OperatingIncomeLoss_1_Q2_USD":-71837000.0,"ForeignCurrencyTransactionGainBeforeTax_2_Q2_USD":10287000.0,"InvestmentIncomeInterest_2_Q2_USD":146000.0,"InvestmentIncomeInterest_1_Q2_USD":38000.0,"OperatingLeaseCost_2_Q2_USD":1458000.0,"OperatingLeaseCost_1_Q2_USD":729000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":135773000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12330000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":14736000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6924000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":422505.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1657000.0,"OperatingExpenses_2_Q2_USD":138851000.0,"OperatingExpenses_1_Q2_USD":71837000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":0.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.12,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.75,"OtherLiabilitiesNoncurrent_0_Q2_USD":4968000.0,"StockholdersEquity_0_Q2_USD":-199779000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":734000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":1386000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8484057.0,"VariableLeaseCost_1_Q2_USD":100000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1068000.0,"Ticker":"MYOV","CIK":"1679082","name":"MYOVANT SCIENCES LTD.","OfficialName":"Myovant Sciences Ltd. Common Shares","form":"10-Q","period":"20200930","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1001965304.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201112"}]